Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_23854796 Show fit | 0.77 |
ENST00000290271.7
|
stanniocalcin 1 |
|
chr5_-_159099909 Show fit | 0.59 |
ENST00000313708.11
|
EBF transcription factor 1 |
|
chr7_-_140176970 Show fit | 0.32 |
ENST00000397560.7
|
lysine demethylase 7A |
|
chr10_+_61901678 Show fit | 0.31 |
ENST00000644638.1
ENST00000681100.1 ENST00000279873.12 |
AT-rich interaction domain 5B |
|
chr2_+_176122712 Show fit | 0.30 |
ENST00000249499.8
|
homeobox D9 |
|
chrY_+_12904860 Show fit | 0.29 |
ENST00000336079.8
|
DEAD-box helicase 3 Y-linked |
|
chr2_-_86337654 Show fit | 0.28 |
ENST00000165698.9
|
receptor accessory protein 1 |
|
chr6_+_21593742 Show fit | 0.25 |
ENST00000244745.4
|
SRY-box transcription factor 4 |
|
chr9_-_137302264 Show fit | 0.25 |
ENST00000356628.4
|
NOTCH regulated ankyrin repeat protein |
|
chr2_+_176116768 Show fit | 0.25 |
ENST00000249501.5
|
homeobox D10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.3 | GO:0035905 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |